At a glance
ClinicalIndex Comparison Record- ✓Children ages 1-8 years old
- ✓Discharge from emergency department or outpatient clinic with diagnosis of asthma exacerbation after standard care
- ✓Able to demonstrate efficient use of a jet nebulizer
- ✕Requiring hospitalization
- ✕Received oral steroids within 1 week prior to ED presentation
- ✕FEV1 <50% of predicted
- ✕Co-morbid renal or cardiovascular disease
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency Department/Outpatient Care Facility
In Brief
A Phase 4 clinical trial evaluating Nebulized Budesonide and Usual care (albuterol with or without oral steroid) for Asthma. Completed, enrolled 61 participants across 2 sites.
Detailed Summary
Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.
Study Details
Timeline
Interventions
Subject is treated with nebulized budesonide 0.5 BID for 3 weeks
Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)